SS
Shankar Srinivasan
About Shankar Srinivasan
Data last updated:
Shankar Srinivasan is a Nominee Director at Alps Remedies Private Limited (since 2017), Nominee Director at Synergy Medicines Private Limited (since 2016) and Director at Healingcross Pharma Private Limited (since 2016), and holds 5 more current directorships. The companies operate in Pharma, Entertainment and Chemicals. The 6 current companies with reported revenue have a combined latest revenue of ₹3.84 Cr; the largest is Alps Remedies Private Limited at ₹3.42 Cr (FY 2025). Earlier, Shankar Srinivasan was a Nominee Director at Sparkwater Productions (India) Private Limited (2019–2025) and Additional Director at Exind Trading Private Limited (2019–2020) and 24 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alps Remedies Private Limited U27239MH1985PTC037680 | Nominee Director | 27 Feb 2017 | 1985 | ₹3.42 Cr (FY 2025) | Active |
| Synergy Medicines Private Limited U24230MH2005PTC153054 | Nominee Director | 23 Dec 2016 | 2005 | ₹20.5 Lakh (FY 2025) | Active |
| Healingcross Pharma Private Limited U24239MH2000PTC123771 | Director | 21 Mar 2016 | 2000 | ₹10.7 Lakh (FY 2025) | Active |
| Famid Sports Private Limited U92100MH2008PTC189174 | Nominee Director | 04 Aug 2009 | 2008 | ₹7.8 Lakh (FY 2017) | Active |
| Uni World Pharma Private Limited U24239MH2000PTC130004 | Director | 23 Dec 2016 | 2000 | ₹2.6 Lakh (FY 2024) | Active |
| Nce Research Labs Private Limited U73100MH1999PTC122759 | Nominee Director | 01 Jun 2023 | 1999 | ₹6,454 (FY 2017) | Active |
| A11 Finbiz Llp AAV-3875 | Designated Partner | 08 Jan 2021 | 2021 | Active | |
| Mn Rajkumar Garments Llp AAB-4854 | Designated Partner | 08 Aug 2017 | 2013 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Sparkwater Productions (India) Private Limited U92100MH2005PTC150994 | Nominee Director | 17 Oct 2019 | 2005 | ₹4.1 Lakh (FY 2025) | Active |
| Exind Trading Private Limited U51909MH2004PTC149452 | Additional Director | 25 Sep 2019 | 2004 | ₹7.8 Lakh (FY 2017) | Converted To Llp |
| Exind Trading Llp AAS-0913 | Designated Partner | 28 Feb 2020 | 2020 | Strike Off | |
| Medule Pharma Llp AAF-7016 | Designated Partner | 30 Dec 2016 | 2016 | Strike Off | |
| Advanced Remedies Llp AAF-8772 | Designated Partner | 30 Dec 2016 | 2016 | Strike Off | |
| Oncocare India Llp AAF-6439 | Designated Partner | 15 Mar 2017 | 2016 | Strike Off | |
| Nebumed Pharma Llp AAF-6608 | Designated Partner | 15 Mar 2017 | 2016 | Strike Off | |
| One World Pharma Llp AAN-6813 | Designated Partner | 10 Dec 2018 | 2018 | Strike Off | |
| Inhaled Technologies Llp AAF-9288 | Designated Partner | 15 Mar 2017 | 2016 | Strike Off | |
| Mediorals Laboratories Llp AAI-5407 | Designated Partner | 12 Feb 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shankar Srinivasan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Farida Yusuf Hamied | 02583027 | Alps Remedies Private Limited | Director |
| Kamil Hamied | 00024292 | Alps Remedies Private Limited , Famid Sports Private Limited | Director |
| Raman Parameswaran Athipotta | 00025481 | Alps Remedies Private Limited | Nominee Director |
| Rumana Hamied | 00024259 | Synergy Medicines Private Limited , Famid Sports Private Limited and 1 more | Nominee Director |
| Shirin Hamied | 00024226 | Synergy Medicines Private Limited , Nce Research Labs Private Limited and 1 more | Director |
| Srinivas Hariharan | 00026785 | Healingcross Pharma Private Limited , Uni World Pharma Private Limited | Director |
| Yusuf Hamied Khwaja | 00029049 | Famid Sports Private Limited | Director |
| Meenu Shankar | 09022902 | A11 Finbiz Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shankar Srinivasan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shankar Srinivasan
Shankar Srinivasan currently holds 8 directorships: Alps Remedies Private Limited (Nominee Director, since 27 Feb 2017, revenue ₹3.42 Cr (FY 2025)); Synergy Medicines Private Limited (Nominee Director, since 23 Dec 2016, revenue ₹20.5 Lakh (FY 2025)); Healingcross Pharma Private Limited (Director, since 21 Mar 2016, revenue ₹10.7 Lakh (FY 2025)); Famid Sports Private Limited (Nominee Director, since 04 Aug 2009, revenue ₹7.8 Lakh (FY 2017)); Uni World Pharma Private Limited (Director, since 23 Dec 2016, revenue ₹2.6 Lakh (FY 2024)); and 3 more.
Shankar Srinivasan was first appointed on 04 Aug 2009 as Nominee Director at Famid Sports Private Limited. The most recent appointment on record is 01 Jun 2023 at Nce Research Labs Private Limited.
The 6 current companies of Shankar Srinivasan that report revenue have a combined latest revenue of ₹3.84 Cr: Alps Remedies Private Limited ₹3.42 Cr (FY 2025); Synergy Medicines Private Limited ₹20.5 Lakh (FY 2025); Healingcross Pharma Private Limited ₹10.7 Lakh (FY 2025); Famid Sports Private Limited ₹7.8 Lakh (FY 2017); Uni World Pharma Private Limited ₹2.6 Lakh (FY 2024); and 1 more.
Shankar Srinivasan held 26 earlier board appointments: Sparkwater Productions (India) Private Limited (Nominee Director, 17 Oct 2019 to 20 Sep 2025); Exind Trading Private Limited (Additional Director, 25 Sep 2019 to 27 Feb 2020); Exind Trading Llp (Designated Partner, from 28 Feb 2020); Medule Pharma Llp (Designated Partner, from 30 Dec 2016); Advanced Remedies Llp (Designated Partner, from 30 Dec 2016); and 21 more.
The current boards of Shankar Srinivasan's companies include Farida Yusuf Hamied (Alps Remedies Private Limited), Kamil Hamied (Alps Remedies Private Limited), Raman Parameswaran Athipotta (Alps Remedies Private Limited), Rumana Hamied (Synergy Medicines Private Limited), Shirin Hamied (Synergy Medicines Private Limited), Srinivas Hariharan (Healingcross Pharma Private Limited), among others.